Salt Lake City, UT INTRODUCTION AND OBJECTIVES: Density gradient centrifugation (DGC) is the clinical gold standard for clinical sperm preparation for normal samples. However, the preparation technique is time consuming, requires a trained technician, and exposes the sperm to large centrifugal forces. In this work, we aim to develop a novel microfluidic device to isolate motile sperm from the ejaculate for use in artificial insemination that will be faster and gentler than DGC.
INTRODUCTION AND OBJECTIVES: Density gradient centrifugation (DGC) is the clinical gold standard for clinical sperm preparation for normal samples. However, the preparation technique is time consuming, requires a trained technician, and exposes the sperm to large centrifugal forces. In this work, we aim to develop a novel microfluidic device to isolate motile sperm from the ejaculate for use in artificial insemination that will be faster and gentler than DGC.
METHODS: Participants were recruited from our Andrology clinic and were required to adhere to standard collection instructions. To facilitate a paired analysis, semen samples were divided into two equal aliquots and processed either through DGC (column with a 90% isolate and 35% isolate layer) or through our microfluidic device. Following processing, samples were assessed for the total number of motile sperm present in the final prepared sample and differences were reported between the two preparations. Additionally, we assessed the capacity of the microfluidic device to remove round cells from the initial sample following processing.
RESULTS: Our results indicate that our microfluidic device effectively retains more motile sperm than the DGC procedure. Specifically, processing the sperm with the microfluidic device allows us to recover 60-80% of the motile sperm depending on operating protocol. In addition, the sperm experience significantly less force in the microfluidic device (w6.2g for less than one second) than through a DGC sperm preparation (400g for 25 minutes). Further, the microfluidic separation also has the ability to remove virtually all round cells from the sample. CONCLUSIONS: Our microfluidic device is capable of preparing a sperm sample for insemination by capturing 60-80% of all motile sperm that were present in the original sample and removing the majority of somatic cells. The microfluidic approach merits investigation as a replacement for a DGC because it is faster, gentler, and retains a higher portion of motile cells than DGC. Further, the system is compatible with automation, which could allow clinics in remote areas to begin to perform IUI without the technician/lab that is support currently required.
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MP52-06 MICROFLUDIC SPERM SORTING BY USING MICROCHIP AS A NEW METHOD FOR REPATED IVF FAILURE CASES: COMPARISON ITS' EFFECT WITH CONTROL GROUP AND PRELIMINARY RESULTS
Mehmet Murad Basar*, Istanbul, Turkey; Hakan Yelke, Istanbul, Turkey; Serkan Selimoglu, Istanbul, Turkey; Emre Soysal, Istanbul, Turkey; Yesim Kumtepe-Colakoglu, Semra Kahraman, Istanbul, Turkey INTRODUCTION AND OBJECTIVES: Microfludic sperm sorting is a new method of sperm selection for ART procedures. The aim of the study was to evaluate the efficacy of this method for sperm sorting in infertile cases which had a repeated implantation failure history, and compared their fertilization rate to control cases.
METHODS: A total of 45 patients having repeated implantation failure previously enrolled into the study. The patients were evaluated with a detailed medical history and a comprehensive physical examination, all probable risk factors were recorded. Semen analysis was assessed according to WHO 2010 guideline. Sixty infertile cases in the same age to whom ART procedure applied were selected as control group. Additionally, microfludic system used cases were divided into two groups according to different systems performed for sperm sorting: Group-I: Fertile and Group-II: Fertile Ultimate. Patients' age, sperm parameters, and embryologic data were compared between two groups by using Student-t, Mann-Whitney U and Pearson X 2 tests. RESULTS: Patients and control group data were given in CONCLUSIONS: While microfluidic sperm sorting system is a new method for sperm selection in IVF laboratory unit, there is not enough data about the clinical outcome. We need further studies about their clinical efficacy.
INTRODUCTION AND OBJECTIVES:
Prior studies have examined sperm retrieval rates in men with non-obstructive azoospermia (NOA) secondary to specific etiologies (Y-chromosome and karyotype abnormalities). We compared sperm retrieval and testicular histopathology in non-idiopathic and idiopathic NOA.
METHODS: Retrospective review of men with NOA who underwent microdissection testicular sperm extraction (microTESE) between 2000 and 2016. Men were classified as idiopathic if they had no history of malignancy or cryptorchidism and routine genetic evaluation was negative. Demographic and clinical variables including age, preoperative testosterone (T), and follicle stimulating hormone (FSH) were abstracted. Multivariable regression was used to determine the association between idiopathic etiology and primary outcomes of sperm retrieval and spermatogenesis on histopathology.
RESULTS: Among the total cohort (N[224), 86 (38.4%) were idiopathic, 75 (33.5%) non-idiopathic, and 63 (28.1%) did not undergo genetic evaluation. Non-idiopathic etiologies included cryptorchidism (N[15), malignancy (N[30), and genetic abnormality (N[28) . Two additional patients had both cryptorchidism and malignancy. Median age (years) was higher among idiopathic ( Sperm retrieval rates were similar between idiopathic and nonidiopathic NOA (41.8% vs 48.0%, p[0.4). Spermatogenesis was seen in a higher proportion of men with idiopathic versus non-idiopathic NOA, approaching but not reaching significance (31.4% vs 16.0%, p[0.07). On multivariable analysis, idiopathic etiology was not associated with sperm retrieval or spermatogenesis (p[0.27 and p[0.07) .
CONCLUSIONS: Rates of sperm retrieval and spermatogenesis on testis pathology are similar in men with idiopathic and non-idiopathic NOA. These data may be useful to clinicians in preoperative counseling for men with NOA and negative genetic evaluation.
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MP52-08 PREOPERATIVE AND INTRAOPERATIVE CHARACTERISTICS OF MEN WHO IMPROVED AND DID NOT IMPROVE SEMEN PARAMETERS AFTER MICROSURGICAL VARICOCELECTOMY
Filipe Lira Neto*, Ricardo Jose Lisboa Lyra, Jarys Cabral Borges Junior, Recife, Brazil INTRODUCTION AND OBJECTIVES: Varicocele is responsible for 35% of primary male infertility cases and found in 80% of men with secondary infertility. Varicocele is also considered the most common correctable cause of male infertility, and microsurgical varicocelectomy (MV) is its gold-standard treatment. Semen parameters improve in up to 80% of infertile men who underwent MV, but there are no clear cut-off values for parameters that can predict a successful outcome after MV. The objective of this study is to compare pre-and intraoperative features of men who improved and did not improve semen parameters after VM.
METHODS: We reviewed a database of 85 infertile men submitted to MV by a single surgeon and identified 51 men who were not azoospermic at baseline and that had postoperative semen analysis data. We defined improvement as an increase of more than 10% in the total progressive motile sperm count (TMPS), and we divided the men in two groups: improved (IG) and non-improved (NIG). Preoperative and intraoperative variables were compared between the two groups.
RESULTS: The IG was composed by 33 (65%) men and the NIG by 18 (35%) men. The IG had a median improvement in the TMPS of 29.0 million/mL and the NIG had a median decrease in the TMPS of 1.2 million/mL. Both groups did not differ regarding mean age, BMI, but the IG had larger testes on physical exam, and larger left vein diameters. There was also a trend to higher varicocele grade on the right side for the IG group. No other intraoperative findings were different between groups. In addition, testosterone, estradiol and follicle stimulating hormone levels were similar in both groups (Table 1) .
CONCLUSIONS: Men who improved semen parameters after MV seem to have larger varicoceles and larger testicular size where compared with those that did not improve.
